Takeaway
- Systolic BP (SBP) increases even within normal range are linked to increased risk for atherosclerotic cardiovascular disease (ASCVD).
- The stepwise risk increase begins with SBP as low as 100 mmHg.
Why this matters
- The authors call for “primordial prevention” of ASCVD by limiting BP increases within normal range, as opposed to delaying to primary prevention once hypertension develops.
- Editorial endorses the inference from these findings that SBP increases well within normal range can contribute to ASCVD risk.
Key results
- Overall median (interquartile range) 10-year ASCVD risk was 3.0% (95% CI, 1.1%-6.7%).
- With SBP
- With every 10-mmHg SBP increase, the aHR for ASCVD was 1.53 (95% CI, 1.17-1.99).
- Using SBP 90-99 mmHg as reference, ASCVD risk (aHRs; 95% CIs) by normal SBP ranges:
- 100-109 mmHg: 3.00 (1.01-8.88).
- 110-119 mmHg: 3.10 (1.03-9.28).
- 120-129 mmHg: 4.58 (1.47-14.27).
Study design
- Cohort study with 1457 participants without ASCVD in the US Multi-Ethnic Study of Atherosclerosis.
- Participants had normal cholesterol, were nonsmokers, and were not taking antihypertensives at entry.
- Funding: National Heart, Lung, and Blood Institute; others.
Limitations
- Did not account for behavioral risk factors.
Dieser Volltext ist leider reserviert für Angehöriger medizinischer Fachkreise
Sie haben die Maximalzahl an Artikeln für unregistrierte besucher erreicht
Kostenfreier Zugang Nur für Angehörige medizinischer Fachkreise